RHYTHM PHARMACEUTICALS, INC.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
RYTM$113.94+1.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | ||||
|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | Date | Number |
| 3.1 | Amended and Restated Certificate of Incorporation of Rhythm Pharmaceuticals, Inc. dated October 10, 2017, and the Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Rhythm Pharmaceuticals, Inc. dated June 25, 2025. | 8-K | 06/26/2025 | 3.1 |
| 3.2 | Amended and Restated Bylaws. | 8-K | 12/18/2023 | 3.1 |
| 3.3 | Certificate of Designations | 8-K | 04/16/2024 | 3.1 |
| 3.4 | Amended and Restated Certificate of Designations | 10-Q | 05/07/2024 | 3.4 |
| 4.1 | Form of Indenture | S-3ASR | 2/26/2026 | 4.3 |
| 10.1* | Rhythm Pharmaceuticals, Inc. Deferred Compensation Plan (Directors) | |||
| 31.1* | Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350). | |||
| 31.2* | Certification of the Principal Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350). | |||
| 32.1** | Certification of the Principal Executive Officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350). | |||
| 32.2** | Certification of the Principal Financial Officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350). | |||
| 101.INS* | Inline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. | |||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | |||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |||
*Filed herewith.
**Furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.